| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |